showed a trendp = 0.443
Only the new eqcopivirus showed a trend toward a higher rate of detection in plasma from unexplained respiratory cases (30% versus 17%) ( p = 0.443).
Only the new eqcopivirus showed a trend toward a higher rate of detection in plasma from unexplained respiratory cases (30% versus 17%) ( p = 0.443).
MED showed a trend to increase in both groups comparing MED at 8 weeks to baseline (AVO: p = .447; CTR: p = .0973), and there was no difference between the AVO and CTR group after 8 weeks (Table 2 ). 3.3.
The degree of improvement in the modified McCormick scale showed a trend towards improvement in patients with IM tumors who achieved gross total removal ( p =0.447).
Marital status was also a significant factor, as divorced/separated caregivers were associated with lower odds of a positive test (aOR = 0.38, 95% CI: 0.16–0.92, *p* = 0.033) compared to married caregivers, while single caregivers showed a trend of higher odds (aOR = 1.30, CI: 0.66–2.59, p = 0.447).
At 5 rpm, the treatment group showed a trend toward improvement at week 8 ( p = 0.45) and a statistically significant enhancement at week 12 ( p < 0.001).
On analysis, although ESPB group showed a trend towards earlier ambulation; the difference was not statistically significant (WMD = −7.23, 95% CI [−24.00, 9.55], p = 0.45; I 2 = 96.28%, p < 0.001), as shown in Fig. 5 . 3.4.3.
In terms of impact of location on efficacy, pancreatic NETs showed a trend of higher ORR (33.3% vs. 22.2%, p = 0.45) than extra-pancreatic NETs in this cohort.
Foraging time was not significantly affected by ammonia nitrogen concentration but showed a trend of first increasing and then decreasing (F 3,44 = 0.893, p = 0.452) ( Figure 4 D).
However, sequestrectomy showed a trend toward better outcomes compared to both partial mandibulectomy (OR=0.34, P= 0.459) and conservative treatment (OR=0.20, P= 0.117).
The intermediate risk group showed a trend to reduction in mortality (17.8% to 10.3%, aHR 0.82, p = 0.46) which was not observed in the low risk group (7.8% to 9.2%, aHR 1.4, p = 0.31).
The health-related quality of life showed a trend towards improvement 4 months after treatment (n = 5, median pedsQL prior to treatment 84.4%, 4 months after treatment 92.4%, p = 0.46).
Overall analysis indicated that exercise intervention showed a trend to increases of muscle strength and power (ES = 0.23, 95% CI [−0.01, 0.47], heterogeneity: p = 0.460, I 2 = 0%, random‐effect model: p = 0.060) (Figure 5 ).
The median operation time showed a trend toward a longer duration in the TTL than in the STL group, albeit not significantly so ( p = 0.460).
Control mice ( Fig 3A ) showed a trend to interact more with the novel object (not significant, p = 0.466) and Tg2576 mice showed a trend to interact less with the novel object (not significant, p = 0.257).
The sauna group showed a trend of lesser pain intensity when compared to control group (P = 0.47; power = 0.11) ( Figure 2 ).
Unlike the CDR, although the overall P ‐value for PAs was not significant ( P = 0.76), post hoc analyses demonstrated that caregivers of GDS 2 individuals showed a trend to report more PAs than GDS 1 ( P = 0.47) and no differences compared to GDS 3 individuals ( P = 0.67).
Analysis of the histological subtypes showed a trend towards higher TAM numbers in iron positive samples of adenocarcinoma (p = 0.4728) (Fig. 3C ), while in squamous cell carcinoma no difference was observed (p = 0.6893) (Fig. 3D ).
VEGF levels also showed a trend toward higher values in the POAF group (834.7 vs. 577.2 pg/mL, p = 0.48).
Although no statistically significant effects were reached, the use of vitamin D supplementation showed a trend for reduced mortality [odds ratio (OR) 0.74, 95% confidence interval (CI) 0.32–1.71, p = 0.48] compared with the control group, with even stronger effects, when vitamin D was administered repeatedly (OR 0.33, 95% CI 0.1–1.14).
20 , 23 , 30 , 34 , 35 Our meta-analyses showed a trend toward a positive association that was not statistically significant (overall OR, 1.14; 95% CI = 0.96, 1.35) with low heterogeneity ( I 2 = 0%; P = 0.480) (Figure 3 ).
The two non-manifesting individuals carrying a heterozygous PRKN variant, and the homozygous PRKN -PD patient showed a trend towards a decreased basal OCR level compared to the control group (controls 0.73 ± 0.1 vs. 0.55 ± 0.1 vs. 0.45 ± 0.17; p = 0.48, p = 0.29) (Fig. 3c ).
Soil enzymatic activities also showed a trend of decrease during the consecutive ratooning; however, the matrices of dissimilarity (NMDS) were statistically not significant ( R = 0.15, P = 0.482) ( Figure 3B ).
Even ex-smoking status showed a trend of effect on protection against COVID-19 (HR 0.882, 95%CI 0.619–1.255, p = 0.485).
Adding 2D E max to B-mode US showed a trend towards improved specificity, but there were no notable distinctions (60% vs. 54.5%, P = 0.488).
In this study, there was no significant difference in postoperative complications between the intervention and untreated groups, although the intervention group showed a trend toward fewer complications (32.8% vs. 41.9%, P=0.49).